Andrew Farquharson serves as Executive at Rani Therapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Andrew Farquharson has executed 9 insider transactions totaling $853.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 23, 2022 involved exercising options for 7,694 shares valued at $0.
Andrew Farquharson currently holds 72,818 shares of Rani Therapeutics Holdings, Inc. (RANI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Farquharson has been a net seller of RANI stock. They have purchased $0 and sold $853.7K worth of shares.
Andrew Farquharson's most recent insider trade was on Aug 23, 2022, when they sold 7,694 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 17, 2022 | RANI | $107.0K | Sale | 9,210 | $11.62 | Discretionary |
| Aug 17, 2022 | RANI | $746.7K | Sale | 71,042 | $10.51 | Discretionary |
| Mar 7, 2022 | RANI | $0 | Other | 2,229,238 | $N/A | Discretionary |
| Mar 7, 2022 | RANI | $0 | Conversion | 2,309,490 | $N/A | Discretionary |
| Mar 7, 2022 | RANI | $0 | Conversion | 2,309,490 | $N/A | Discretionary |
| Feb 3, 2022 | RANI | $0 | Other | 66,127 | $N/A | Discretionary |
| Feb 3, 2022 | RANI | $0 | Other | 827,467 | $N/A | Discretionary |